Stimulation of progesterone secretion by recombinant follistatin-288 in human granulosa cells.

Endocrinology ◽  
1993 ◽  
Vol 132 (4) ◽  
pp. 1750-1756 ◽  
Author(s):  
W Li ◽  
S Khorasheh ◽  
B H Yuen ◽  
N Ling ◽  
P C Leung
Keyword(s):  
Granulosa Cells ◽  
Human Granulosa Cells ◽  
Progesterone Secretion ◽  
Stimulation Of

Effect of Endometriosis on Progesterone Secretion by Human Granulosa Cells: Role of Peritoneal Fluid

2005 ◽  
Vol 84 ◽  
pp. S201-S202
Author(s):  
P.A. Navarro ◽  
F.M. Gomes ◽  
C.C. Petean ◽  
R.M. Dos Reis ◽  
R.A. Ferriani ◽  
...  
Keyword(s):  
Granulosa Cells ◽  
Peritoneal Fluid ◽  
Human Granulosa Cells ◽  
Progesterone Secretion

scholarly journals Progesterone secretion by luteinizing human granulosa cells: a possible cAMP-dependent but PKA-independent mechanism involved in its regulation

2004 ◽  
Vol 183 (1) ◽  
pp. 51-60 ◽  
Author(s):  
E C Chin ◽  
D R E Abayasekara
Keyword(s):  
Protein Kinase ◽  
Adenylate Cyclase ◽  
Granulosa Cells ◽  
Mitogen Activated Protein Kinase ◽  
Dependent Manner ◽  
Nucleotide Exchange ◽  
Independent Manner ◽  
Human Granulosa Cells ◽  
Progesterone Secretion ◽  
Dose Dependent

The corpus luteum formed after luteinization of follicular cells secretes progesterone under the control of luteinizing hormone (LH). Binding of LH to its G-protein-coupled receptor leads to the activation of the adenylate cyclase/ cyclic AMP (cAMP)/cAMP-dependent protein kinase (PKA) signalling pathway. The identification of a new class of cAMP-binding proteins termed ‘guanine nucleotide exchange factors’ (cAMP-GEFs) provides a means by which changes in cAMP could yield actions that are independent of PKA. Hence, in this study, we have explored the hypothesis that steroidogenesis in luteinizing cells is mediated in both a cAMP/PKA-dependent and cAMP-dependent, but PKA-independent, manner. Human granulosa cells were isolated from follicular aspirates of women undergoing assisted conception. Luteinizing human granulosa cells were cultured for up to 3 days in the presence of human (h)LH and the adenylate cyclase activator forskolin in the added presence or absence of increasing doses of the PKA inhibitors H89 (N-[2-(4-bromocinnamylamino)ethyl] 5-isoquinoline) and PKI (myristoylated protein kinase A inhibitor amide 14–22) or the cAMP antagonist, Rp-cAMP. Agonist-stimulated progesterone secretion was inhibited in a dose-dependent manner by the PKA inhibitors and the cAMP antagonist, with decreasing sensitivity as luteinization progressed. Pretreatment of granulosa cells for 4 h with human (h)LH reduced the effectiveness of H89 in inhibiting progester-one secretion. Under basal conditions, cAMP-GEFI expression increased progressively throughout culture, and this could be further enhanced when cells were incubated with increasing doses of LH and forskolin. Furthermore, incubation of cells in the presence of increasing concentrations of the novel cAMP-GEF-specific cAMP analogue, 8 CPT-2 ME-cAMP (8-(4-chloro-phenylthio)-2′-0-methyladenosine-3′,5′-cyclic monophosphate), increased progesterone secretion in a dose-dependent manner. The results show that increases in cAMP generated by LH and forskolin, in addition to activating PKA, also induce increases in cAMP-GEFI protein expression in luteinizing human granulosa cells. In addition, activation of cAMP-GEFI results in increased progesterone secretion. Hence, increases in cAMP lead to the activation of PKA-dependent, as well as PKA-independent but cAMP-dependent (via cAMP-GEFI), signalling mechanisms. Since cAMP-GEFs have the capacity to activate the mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3-K)/protein kinase B (PKB) signalling pathways, these may provide the potential mechanisms by which cAMP-dependent but PKA-independent progesterone synthesis is regulated.

Catecholamines and ascorbic acid as stimulators of bovine ovarian oxytocin secretion

1987 ◽  
Vol 114 (3) ◽  
pp. 423-430 ◽  
Author(s):  
M. R. Luck ◽  
B. Jungclas
Keyword(s):  
Ascorbic Acid ◽  
Granulosa Cells ◽  
Time Course ◽  
Culture Medium ◽  
Stimulatory Action ◽  
Variable Effect ◽  
Progesterone Secretion ◽  
Agonistic Activity ◽  
Cells Cultured ◽  
Stimulation Of

ABSTRACT The effects of catecholamines and ascorbic acid on cultured bovine granulosa cells have been examined to assess their possible role in the initiation and maintenance of luteal oxytocin secretion. The actions of these agents have also been compared with the previously reported ability of follicular theca tissue to enhance oxytocin secretion. Using granulosa cells cultured in serum-supplemented medium, we observed a highly significant enhancement of oxytocin secretion in the presence of adrenaline and noradrenaline, particularly over the concentration range 1–10 μmol/l. This effect was accompanied by smaller and less consistent changes in progesterone secretion and did not involve any change in the time-course of oxytocin secretion. Acetylcholine was without effect. Ascorbic acid stimulated oxytocin secretion when used alone over a range of concentrations, but was also able to synergize with adrenaline. Lactic acid was ineffective. The stimulation of oxytocin secretion by adrenaline could be blocked by equimolar propranolol, but the stimulation of progesterone was not blocked. Propranolol had a variable effect on the ability of theca tissue to stimulate oxytocin secretion by granulosa cells but the results also suggested the presence of some β-agonistic activity in the culture medium. We conclude, first, that catecholamines may be involved in the regulation of ovarian oxytocin secretion, secondly, that ascorbate may regulate oxytocin secretion through its involvement in the biosynthesis of oxytocin but also through interaction with catecholamines and, thirdly, that the stimulatory action of theca tissue probably does not involve the action of β-agonists. J. Endocr. (1987) 114, 423–430

scholarly journals Deficiency of Scavenger Receptor Class B Type I Negatively Affects Progesterone Secretion in Human Granulosa Cells

Endocrinology ◽  
2010 ◽  
Vol 151 (11) ◽  
pp. 5519-5527 ◽  
Author(s):  
Antonina Kolmakova ◽  
Jiangxia Wang ◽  
Rebecca Brogan ◽  
Charles Chaffin ◽  
Annabelle Rodriguez
Keyword(s):  
Granulosa Cells ◽  
Regulatory Protein ◽  
Scavenger Receptor ◽  
Ldl Receptor ◽  
Density Lipoprotein ◽  
Type I ◽  
Human Granulosa Cells ◽  
Scavenger Receptor Class ◽  
Progesterone Secretion ◽  
Class B

Our goal was to examine the effect of deficiency of the lipoprotein receptor, scavenger receptor class B type I (SR-BI), on progesterone secretion in human granulosa cells (HGL5). Scrambled or SR-BI small interfering RNA [knockdown (KD)] cells were exposed to dimethylsulfoxide [DMSO, vehicle for forskolin (Fo)], Fo, serum, high-density lipoprotein, low-density lipoprotein (LDL), or Fo plus lipoproteins or serum for 24 h. Progesterone secretion was lower in all of the SR-BI KD cells regardless of treatment. We examined progesterone secretion in SR-BI KD, LDL receptor KD, and double KD cells incubated with DMSO, Fo, LDL, or Fo + LDL for 6–24 h. As compared with scrambled cells, progesterone secretion was lower in SR-BI and double KD cells regardless of treatment; whereas progesterone secretion was only lower in LDL receptor KD cells incubated with LDL and Fo + LDL. We measured phosphorylation of hormone-sensitive lipase (pHSL) expression, intracellular total cholesterol (TC) mass, and progesterone secretion in scrambled and SR-BI KD cells incubated with DMSO or Fo for 2–24 h. The expression of pHSL was similar between the cells and conditions. The mean change in TC mass and progesterone secretion was lower in SR-BI KD cells exposed to DMSO and Fo. Incubating SR-BI KD cells with 22-hydroxy cholesterol did not overcome the reduction in progesterone secretion. At different time points, RNA expression of steroidogenic acute regulatory protein, side-chain cleavage, and 3β-hydroxysteroid dehydrogenase was significantly lower in SR-BI KD cells incubated with Fo. In conclusion, SR-BI protein deficiency, in part, might explain progesterone deficiency in some infertile women.

Sign in / Sign up

Export Citation Format

Share Document